Diagnosis, Management, and Genetics of hATTR Amyloidosis | Webinar | Ambry Genetics

For more information on genetic testing, visit www.ambrygen.com
In this webinar, you will learn how to:
Master the nomenclature used to identify the varying forms of amyloidosis
Discuss the various types of amyloidosis and distinguish wild-type TTR from mutant type TTR
Compare the clinical presentations seen with the various forms of amyloidosis and how they lead to patient's symptoms
Demonstrate understanding of the genotype-phenotype correlations in TTR amyloidosis
Illustrate common challenges in genetic counseling of patient and families with TTR amyloidosis
Presented by:
Morie Gertz, MD, MACP | Presenter
Consultant, Division of Hematology, Department of Internal Medicine, Mayo Clinic
Dr. Gertz is the Roland Seidler Jr. Professor of the Art of Medicine and Chair Emeritus of the Department of Internal Medicine, at Mayo Clinic in Rochester, Minnesota. He is a Master of the American College of Physicians. Undergraduate degree was awarded with highest distinction from Northwestern University graduating Phi Beta Kappa. Dr. Gertz received his medical degree cum laude from Loyola Medical School in Maywood, Illinois and was elected to Alpha Omega Alpha the medical honor society. He completed a 3-year medical residency at Rush Presbyterian St. Luke’s Hospital in Chicago, Illinois, and was voted Resident of the Year for 2 of those years. He completed training in hematology and oncology at the Mayo. He was awarded the Mayo Distinguished Clinician Award for his contributions to patient care. He was the first treasurer of the International Society of Amyloidosis and International Myeloma Society. He has authored over 700 peer reviewed publications and over 50 book chapters. He serves on the editorial boards of Amyloidosis, Acta Haematologica and Clinical Lymphoma & Myeloma. He is coeditor of Neoplastic Diseases of the Blood. In 2019 The Department of Medicine awarded him its lifetime research achievement award.
Katie Agre, MS, LCGC | Presenter
Genetic Counselor, Department of Cardiovascular Diseases, Mayo Clinic
Katie received her masters of science in Genetic Counseling from the University of Minnesota. She works as a clinical genetic counselor in the Department of Cardiovascular Diseases at Mayo Clinic in Rochester, Minnesota.
Ben Feldmann, MS, MB (ASCP) | Moderator
Sr. Manager, Genomic Science Liaison
Ben Feldmann leads Ambry’s Specialty Genomic Science Liaison team, responsible for providing clinical education and support for all non-oncology sections of Ambry’s test menu. Ben received his BS degree in Biology from Xavier University and MS in Molecular Diagnostic Science from the University of North Carolina at Chapel Hill. He held previous positions at Cincinnati Children’s Hospital in the Heart Institute Diagnostic Lab and the Division of Pulmonary Biology. He is a board certified member of the American Society for Clinical Pathology. Ben has a special interest in the genetics of hypertrophic cardiomyopathy, sudden cardiac arrest, and family cascade testing.

[@gmorris22]

I have a sister that is 52 and was diagnosed with HCM. Our mother had a defibrillator and passed away from heart disease at 71. I decided to get a 23andme test and it came back that I had tested positive for V122I. I let my primary care doctor know and I having an echo done next week.